Baird Global Healthcare Report 2016-2017 Global Healthcare Report - Page 9

As genome sequencing technology advances, corporates will gain more and better insight into existing genetic mutations, appropriate therapies for patients, and whether clinical studies are suitable for those patients. Ultimately, the cost and the accuracy of this technology must continue to improve if it is to become widely adopted. There’s a lot of discussion about the possibility of genome sequencing over the course of a lifetime – at birth, perhaps at several other points. Obviously, there are a lot of ethical issues and cost implications for this. First, is the test going to be cheap enough to allow for this? What’s the true benefit of this type of testing? Who will pay? Is it an out-of-pocket expense, or would it fall to a commercial payer, a government payer or some type of a foundation? MANISH GUPTA Patients, payers and healthcare providers will all benefit as technology and conventional healthcare continue to converge. This ongoing evolution is already yielding a number of compelling, transformative monitoring technologies. The miniaturization of monitoring devices – such as those included in popular wearables – allows individuals to have an array of capabilities embedded in a simple device that enables users to get and remain healthy. Additionally, innovative remote patient monitoring technologies are playing a key role in minimizing “never events” in hospitals. These developments benefit both patients and healthcare providers and save billions of dollars in healthcare expenditures. DAVID SCHECHNER Numerous areas of Biotech – gene therapy, the microbiome, others – haven’t developed a drug yet, but there is significant enthusiasm for these areas among companies, investors and other players in the industry. At the end of the day, though, the biggest beneficiary is the patient. Payers, corporates and healthcare systems will find ways to adjust to the structural changes in their service models, but the Healthcare industry exists to improve human health. The goal of all of these developments is, ultimately, to save lives. 7